Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Jan;347(1):9-13.
doi: 10.1007/BF00168765.

Effects of morphine on release of acetylcholine in the rat striatum: an in vivo microdialysis study

Affiliations

Effects of morphine on release of acetylcholine in the rat striatum: an in vivo microdialysis study

K Taguchi et al. Naunyn Schmiedebergs Arch Pharmacol. 1993 Jan.

Abstract

We examined the effect of morphine on the release of acetylcholine (ACh) in the striatum of freely moving rats using the in vivo microdialysis method. The basal level of ACh was 3.01 +/- 0.51 pmol/30 microliters/15 min in the presence of neostigmine (10 microM). Tetrodotoxin (1 microM), a selective blocker of voltage-dependent Na+ channels, rapidly decreased the release of ACh in the striatal perfusates. Morphine at a dose of 10 mg/kg (i.p.) caused a reduction of ACh release in the striatum at 90-150 min. However, a lower dose of morphine (5 mg/kg, i.p.) did not affect ACh release in the striatum. The reduction following intraperitoneal administration of morphine was abolished by naloxone (1.0 mg/kg). After microinjection of the neurotoxin 6-hydroxydopamine (6 micrograms/3 microliters, 7 days before) in the substantia nigra, the morphine (10 mg/kg)-induced decrease of ACh was attenuated, and a similar result occurred following reserpine (2 mg/kg, i.p.) 24 h before combined with alpha-methyl-p-tyrosine (300 mg/kg, i.p.) 2.5 h before. These findings indicate that morphine exerts an inhibitory influence on striatal ACh release in freely moving rats and that this inhibitory effect is mediated by the nigro-striatal dopaminergic system.

PubMed Disclaimer

References

    1. Brain Res. 1982 Nov 4;250(2):263-70 - PubMed
    1. Br J Pharmacol. 1980;71(1):201-10 - PubMed
    1. J Pharmacol Exp Ther. 1982 Jan;220(1):197-202 - PubMed
    1. Nature. 1981 May 28;291(5813):320-2 - PubMed
    1. Br J Pharmacol. 1982 Jul;76(3):393-401 - PubMed